Soliris reduces blood clots in PNH
A study designed to examine the effect of long-term treatment with Soliris (eculizumab) in individuals with paroxysmal nocturnal hemoglobinuria (PNH), a disorder in which abnormal breakdown of red blood cells… …
Original post by (Reuters)
Leave a Reply